INTRODUCTION
============

Since the special quartz fiberoptic transmission system was developed, it is possible to apply laser energy through a flexible fiber endoscope.

After the first use of the endoscopic laser for the treatment of active gastrointestinal bleeding in 1975, by Fruhmorgen, endoscopic laser therapy has been widely used, not only for the treatment of acute gastrointestinal bleeding and non-bleeding gastrointestinal angiodysplasia, but also for the treatment of gastrointestinal neoplasm.

In our experience, the use of the endoscopic Nd-YAG laser for the removal of protruding, broad-based polyps of the stomach is efficient and safe.

SUBJECTS AND METHODS
====================

Twelve patients with broad-based gastric polyps which protruded submitted to the removal of the polyps with an endoscopic Nd-YAG laser ([Table 1](#t1-kjim-1-2-222-14){ref-type="table"}).

The quartz fiber with a polyethylene sheath was guided through the biopsy channel of a prototype panendoscope, GIF-Q10, and GIF-2T. A filtering lens was attached to the eyepiece of the endoscope to prevent damage to the operator's eye from the laser beam.

Multiple 0.5 sec pulse irradiation of the Nd-YAG laser (Medilas YAG, Germany), with a power of 60 watts, at the tip of the quartz fiber were utilized. The flexible light guided assembly was quartz fiber with a diameter of 600 *μ*m, a length of 3--4 m, and a divergence angle of 8.

The tip was positioned at a distance of about 1 cm from the lesion. The application number of laser energy was from 6 to 58 depending on the location and size of the lesion ([Table 1](#t1-kjim-1-2-222-14){ref-type="table"}).

After the laser application, an H~2~ receptor antagonist (Ranitidine) for laser-induced ulcers was administered perorally for four weeks routinely, and all patients except one were submitted to a follow-up gastroscopy 1 week and 5 weeks after the laser application ([Table 2](#t2-kjim-1-2-222-14){ref-type="table"}).

RESULTS
=======

From January to November 1985, endoscopic Nd-YAG laser treatment was utilized to eradicate gastric polyp in 12 patients.

The male to female ratio was 1:1.4 (Male: 5, Female: 7), and ranging, in age from 34 to 70 with a mean of 50 years ([Table 1](#t1-kjim-1-2-222-14){ref-type="table"}).

The most frequent presenting symptoms initiating the diagnostic work up were epigastric discomfort, indigestion or nausea.

The presence of gastric polyp was confirmed by endoscopy and by upper gastrointestinal contrast study.

The most frequent location for the polyp was in the antrum (7 cases) and followed by the fundus (5 cases). Multiple polyps were noted in two cases and they were located in the body or antrum of the stomach.

The number of polyps of type I (Yamada classification) was 7, type II, 5; type III, 2; and type IV, 1 ([Table 1](#t1-kjim-1-2-222-14){ref-type="table"}).

The size of the lesions treated with the laser ranged from 0.2 cm to 1.0 cm in diameter.

The application number of laser energy was from 6 to 58, while the small lesions of the 10 patients were completely ablated by the first endoscopic laser therapy, the other two lesions of the two patients required repetitive laser treatment to achieve complete ablation of the lesion ([Table 2](#t2-kjim-1-2-222-14){ref-type="table"}).

During and after endoscopic laser therapy, no complication were encountered except for mild bleeding and occasional mild epigastric burning pain in the case of two of the patients.

Follow-up endoscopy in all patients, which was done at the ends of the first and fifth weeks after the laser application, revealed no new polyp formation or recurrence. All patients had residual ulcers at the end of the first week postopolypectomy, but all ulcers were healed by the end of the fifth week of follow-up ([Table 2](#t2-kjim-1-2-222-14){ref-type="table"}).

DISCUSSION
==========

With the development of a flexible fiberoptic system, diagnostic and therapeutic endoscopy is playing a major role in the management of gastrointestinal polyps.^[@b1-kjim-1-2-222-14]--[@b5-kjim-1-2-222-14]^

The incidence of gastric polyps is low. A review of several studies has revealed the incidence of adenomatous polyps of the stomach to be 0.4%^[@b6-kjim-1-2-222-14]^ to 0.7%.^[@b7-kjim-1-2-222-14]^

Although the term gastric polyp has been used to refer to any protrusion into the gastric lumen, recent experience has led to classification schemes based on topographic,^[@b8-kjim-1-2-222-14]^ histologic,^[@b9-kjim-1-2-222-14]--[@b12-kjim-1-2-222-14]^ and vital staing^[@b13-kjim-1-2-222-14]^ criteria.

The most frequently encountered gastric polyp, hyperplastic or regenerative polyp, is reported to contain malignancy rarely. The incidence of malignant change in adenomatous polyp has been reported to be from 6 to 75 percent.^[@b14-kjim-1-2-222-14]^ The malignant potential appears to be related to the size of the polyp, with larger adenoms (particularly those greater than 2 cm) having a greater potential for malignant change.^[@b15-kjim-1-2-222-14]^

At the Mayo clinic, patients were offered endoscopic polypectomy if the gastric polyps had been diagnosed and they met one of the following criteria.^[@b1-kjim-1-2-222-14]^ Unchanged or enlarging gastric polyp on serial upper gastrointestinal contrast studies.Expected noncomplaint patient follow-up.Previous gastric surgical procedure with the presence of a new polyp.A gastric polyp in a patient known to have pernicious anemia.

One of the known procedures for the ablation of gastric polyps by endoscope is electro-coagulation with a snare. The complications that can ensue from this snare excision method are bleeding, perforations and ulceration,^[@b1-kjim-1-2-222-14],[@b16-kjim-1-2-222-14]^ and broad based, protruding polyps (such as the Yamada classification type I or type II lesions) are technically difficult to excise by this method.

In the last few years, the use of endoscopic laser for the therapy of gastrointestinal disease has grown exponentially, due to its therapeutic benefit and safety.^[@b17-kjim-1-2-222-14]^

The Nd-YAG lasers are no longer thought of as being investigational for therapy. There are 3 main indications for their use:^[@b18-kjim-1-2-222-14],[@b19-kjim-1-2-222-14]^ Acute gastrointestinal bleeding.Non-bleeding gastrointestinal angiodysplasia.Gastrointestinal neoplasm, where palliation is needed.

The application of the Nd-YAG laser in the treatment of gastrointestinal disorder is still in an evolutionary process.^[@b18-kjim-1-2-222-14]^ One area of interest is the treatment of inoperable neoplasm of the esophagus, stomach, duodenum, and colon. Palliative therapy with an Nd-YAG laser is indicated for obstructing symptoms, bleeding from the malignancy, and tumor bulk.^[@b18-kjim-1-2-222-14]^

The Nd-YAG laser is effective in reducing the size of a mass. The patients with polyps of the gastrointestinal tract, also, have been successfully treated with it. Even benign sessile polyps can be successfully ablated, using it.^[@b18-kjim-1-2-222-14]--[@b21-kjim-1-2-222-14]^

The number of serious complications,^[@b17-kjim-1-2-222-14]^ which can occur during therapy with laser energy, have been impressively few.

Rosch and Fruhmorgen^[@b22-kjim-1-2-222-14],[@b23-kjim-1-2-222-14]^ have reported the efficacy of using the endoscopic argon laser for the gastric borderline lesions and early, protruding gastric carcinoma. Dixon et al.^[@b22-kjim-1-2-222-14],[@b24-kjim-1-2-222-14]^ also treated both gastric and rectal polyps by endoscopic argon laser photocoagulation.

However, there is a tendency toward using the Nd-YAG laser because of its greater power output.^[@b22-kjim-1-2-222-14],[@b25-kjim-1-2-222-14]^ Anthony A. Goossens and his fellow investigators^26)^ reported that the argon laser emits a beam which has lower surface absorption and tissue healing than other lasers, making it ideal for ophthalmological work where high surface tissue absorption is not desired and thermal coagulation at shallow depth is, but since Nd-YAG lasers emit a beam which has low surface absorption and penetrates tissue to more depth than the argon laser beam does, there is enough energy to overcome the dynamic condition of tissue to allow more deep thermal coagulation, tissue destruction, and tumor removal ([Table 3](#t3-kjim-1-2-222-14){ref-type="table"}).

Osamu Kato and his associates reported^[@b22-kjim-1-2-222-14]^ a case of broad-based, protruding gastric borderline lesions, which was successfully treated, using the endoscopic Nd-YAG laser.

We ablated broad-based, protruding gastric polyps of 12 patients without complications, such as the bleeding or perforations, which can ensue from snare excision.

We, therefore, emphasize that endoscopic Nd-YAG laser therapy is an effective and safe method of treatment for ablation of broad-based, protruding polyps of the stomach.

However, long term follow up study should be done, because laser therapy precludes a total biopsy.

![Gastroscopic finding of patient K.S.I ○ Left upper; gastric polyp in antrum○ Right upper; just after laser application○ Left bottom; 1 week after laser application○ Right bottom; 5 weeks after laser application](kjim-1-2-222-14f1){#f1-kjim-1-2-222-14}

![Gastroscopic finding of patient J.K.O. ○ Left; gastric polyp in mid-body○ Center; 1 week after laser application○ Right; 5 week after laser application](kjim-1-2-222-14f2){#f2-kjim-1-2-222-14}

![Gastroscopic finding of patient J.W.H. ○ Left; gastric polyp in angle○ Center; 1 week after laser application○ Right; 5 weeks after laser application](kjim-1-2-222-14f3){#f3-kjim-1-2-222-14}

![Gastroscopic finding of patient K.D.J. ○ Left; gastric polyp in lower body○ Center; 1 week after laser application○ Right; 5 weeks after laser application](kjim-1-2-222-14f4){#f4-kjim-1-2-222-14}

![Gastroscopic finding of patient N.Y.M. ○ Left upper; gastric polyp in antrum○ Right upper; just after laser application○ Left bottom; 1 week after laser application○ Right bottom; 5 weeks after laser application](kjim-1-2-222-14f5){#f5-kjim-1-2-222-14}

###### 

Gastroscopic Findings in Patients with Gastric Polyps

  Patient                     Sex age               Location                       Size (cm)             Yamada classification   Associated disease
  --------------------------- --------------------- ------------------------------ --------------------- ----------------------- --------------------------------------
  L.K.N.                      M/36                  Lower body posterior wall      0.3 × 0.3 × 0.2       Y.II                    
  K.Y.K.                      M/70                  Lower antrum posterior wall    0.5 × 0.4 × 0.2       Y.II                    Chronic atrophic gastritis
  C.S.H.                      F/37                  1\) Antrum greater curvature   0.3 × 0.3 × 0.5       Y.I                     Chronic superficial gastritis
  2\) Lower body              1.0 × 0.8 × 0.8       Y.II                                                                         
  J.D.S.                      F/54                  Lower body anterior wall       0.3 × 0.2 × 0.5       Y.I                     Chronic superficial gastritis
  K.S.I.                      M/34                  Antrum anterior wall           0.3 × 0.3 × 0.5       Y.II                    Acute superficial gastritis
  L.H.B.                      F/67                  Antrum greater curvature       1\) 0.8 × 0.7 × 1.0   Y.IV                    
                              2\) 0.3 × 0.2 × 0.5   Y.I                                                                          
  K.Y.S.                      F/47                  Antrum lesser curvature        0.5 × 0.5 × 0.3       Y.II                    Adenocarcinoma signet ring cell type
  J.K.O.                      F/64                  Mid-body greater curvature     0.3 × 0.2 × 0.3       Y.I                     Chronic superficial gastritis
  J.W.H.                      M/40                  Angle proximal part.           0.3 × 0.5 × 0.3       Y.III                   Chronic hyperplastic gastritis
  K.D.J.                      F/55                  Lower body greater curvature   0.6 × 0.6 × 0.5       Y.III                   
  N.Y.M.                      M/60                  1\) Mid-body anterior wall     0.3 × 0.2 × 0.3       Y.I                     Esophageal varix
  2\) Antrum posterior wall   0.2 × 0.3 × 0.2       Y.I                                                                          
  L.Y.S.                      F/34                  Antrum posterior wall          0.6 × 0.7 × 0.6       Y.I                     

###### 

Laser Application on Gastric Polyps and Follow-up Gastroscopic Findings

  Patient number of applications   Gastroscopic findings after treatment                                                   
  -------------------------------- --------------------------------------- ----------------------------------------------- ------------------------
  L.K.N.                           21                                      Small ulcer with slight hyperemic margin (A2)   Red linear scar (S1)
  K.Y.K.                           58                                      Small ulcer crater with heaped-up margin (A1)   Elevated red scar (H2)
  C.S.H.                           1\) 7,5,6,6                             1\) Small ulcer crater (A1)                     White linear scar (S2)
  2\) 38                           2\) Reapplication (43x)                                                                 
  J.D.S.                           11                                      Ulcer with hyperemic heaped-up margin (A2)      Red scar (S1)
  K.S.I.                           32                                      Ulcer with hyperemic margin (A2)                Red linear scar (S1)
  L.H.B.                           50                                      Ulcer crater (A1)                               White linear scar (S2)
  K.Y.S.                           26                                      Ulcer crater (A1)                               Operation
  J.K.O.                           7                                       Small ulcer with hyperemic margin (A2)          White scar (S2)
  J.W.H.                           50                                      Ulcer with white coated floor (A1)              White scar (S2)
  K.D.J.                           57                                      Round ulcer covered with white floor (A1)       White linear scar (S2)
  N.Y.N.                           1\) 12                                  Ulcer crater (A1)                               Red linear scar (S1)
  2\) 7                            Ulcer crater (A1)                       White linear scar (S2)                          
  L.Y.S.                           27                                      Ulcer with marginal swelling (A1)               White linear scar (S2)

( ) : Analysis of ulcer according to Sakita classification (A1, A2, H1, H2, S1, S2)

###### 

Types of Medical Lasers

  Laser medium   Type of medium   Operating wavelength (*μ*m)   Power (W)    Applications
  -------------- ---------------- ----------------------------- ------------ ------------------------------------------------------------------------------------------------------------------------
  Ruby           Solid            0.69                          1--1000      Ophthalmology
  Krypton        Gas              0.65                          0.5--2.0     Ophthalmology
  Co~2~          Gas              10.6                          10--5000     Gynecology
  He-Ne          Gas              0.63                          0.001--0.1   Ophthalmology
  Dye            Liquid           0.25--0.7                     0.5--5.0     Microsurgery, ophthalmology
  Argon          Gas              0.51/0.49/0.48                1.0--2.0     Ophthalmology
  Nd:YAG         Solid            1.06/1.3                      1--150       Gastroenterology, urology, bronchology, neurology, general surgery, dentistry, pulmonary, dermatology, ENT, gynecology

(From reference 26)
